Frequently Asked Questions For NOT-RM-20-015

We appreciate your interest in the Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-RM-20-015). The following frequently asked questions (FAQs) are specific to NOT-RM-20-015 and will be updated periodically as NIH staff receive questions from potential applicants.


I have a grant, but it is not a Common Fund grant. Can I apply to this NOSI?

My grant, which is not a Common Fund grant, previously received a supplement from the Common Fund. Can that supplement serve as a Common Fund award for eligibility for this NOSI?

Are multiple PI applications allowed?

Are foreign researchers and institutions eligible?

Can NIH intramural investigators apply to PA-20-135?

What mechanisms are eligible?

How do I know if my existing grant is a Common Fund grant since it is administered by one of the Institutes or Centers (ICs)?

If my Common Fund award is on a No Cost Extension (NCE) or soon will be, am I eligible?

Can we have new collaborators on our application that are not funded by the Common Fund, and could such collaborators be Co-investigators or Co-Principal Investigators?

Are subcontracts allowed?


What parent announcement is this Notice of Special Interest (NOSI) related to?

Would you please clarify when the NIH application deadline is?

Will the applicant webinar be posted online afterward?

What is the maximum amount of direct costs available for each project?

May I submit more than one application to the PA-20-135?

May I apply to this NOSI in addition to the COVID-19-related funding opportunities from the other NIH Institutes and Centers (ICs) ?

Do the flexibilities for late application submission apply to this NOSI?

Must my application address a specific scientific area to be considered for funding?

How closely related does my application have to be to the parent grant?

How many years can be proposed for this Competitive Revision?

I am not sure if my idea sufficiently addresses the goals of the NOSI. When should I consider talking to my Program Official (PO)?

Could a principal investigator (PI) apply to the program announcement directly without having to reference the NOSI?

Can my request for a competitive revision exceed the annual budget of my grant?

For administrative supplements, which NOSI number should be entered in in the Agency Routing Identifier field (Box 4b) of the SF424 (R&R) Form?

Can you explain the difference between applying to a competitive revision and an administrative supplement?

Are collaborators on the parent grant required to be included in the NOSI proposal? Or can the application propose a new team for this initiative?

Do we have to use the same title as the parent grant for this NOSI submission?

What information should be included in the Introduction page?

Is this call mainly looking for translational proposals? Or are basic mechanistic ideas also welcome?

Do we have to submit a Specific Aims page and does the Research Strategy have to be 6 pages?

Can a different Principal Investigator from that of the parent award be designated on the application in response to this NOSI?

This NOSI allows applicants to use FORMs- E or FORMS- F. FORMS-E is phasing out, will that work against applicants that use it instead of FORMS-F?

How much preliminary data must one include in their application?

How is the Parent Announcement related to the NOSI?

How much justification is necessary about the relatedness between the revision proposal and the parent award? That is, is there an advantage to more closely tying the revision proposal conceptually to the parent award? Or is it just that once you meet the threshold for relatedness, the proposal is considered on its own merit?

May I apply under this NOSI to this to cover unanticipated expenses for my research project that result from COVID-19?

Regarding the budget being equivalent to up to one year of the parent award, how is this determined for a multi-year funded award like the DP2?

Is the limit to requesting funding based on total costs or direct costs in the parent award?

If the current annual funding is more than $500,000, can one still budget for the actual current award?

Are there any extra budget limitations for subcontracts?

Is it expected or not that the Principal Investigator will request additional salary support on top of what they are drawing from the parent award?


What is the locus of review?

When will applications be reviewed?

Will I receive written comments or feedback from the review?

What criteria will be used to judge the merit of applications?


What is the set-aside for this funding opportunity?

When will the competitive revision projects be funded?

Are carry forwards allowed after one year?

This page last reviewed on July 16, 2020